Repositori institucional URV
Español Català English

TÍTULO:

Bispecific Antibodies, Nanobodies and Extracellular Vesicles: Present and Future to Cancer Target Therapy - imarina:9454145

Autor/es de la URV:Plaza Diaz, Julio Ramon
Autor según el artículo:Lizama-Munoz, Asier; Plaza-Diaz, Julio
Direcció de correo del autor:julioramon.plaza@urv.cat
Identificador del autor:0000-0002-5171-9408
Año de publicación de la revista:2025
Tipo de publicación:Journal Publications
Referencia de l'ítem segons les normes APA:Lizama-Munoz, Asier; Plaza-Diaz, Julio (2025). Bispecific Antibodies, Nanobodies and Extracellular Vesicles: Present and Future to Cancer Target Therapy. Biomolecules, 15(5), 639-. DOI: 10.3390/biom15050639
Referencia al articulo segun fuente origial:Biomolecules. 15 (5): 639-
Resumen:Cancer remains one of the leading causes of mortality worldwide, with a growing need for precise and effective treatments. Traditional therapies such as chemotherapy and radiotherapy have limitations, including off-target effects and drug resistance. In recent years, targeted therapies have emerged as promising alternatives, aiming to improve treatment specificity and reduce systemic toxicity. Among the most innovative approaches, bispecific antibodies, nanobodies, and extracellular vesicles offer distinct and complementary mechanisms for cancer therapy. Bispecific antibodies enhance immune responses and enable dual-targeting of cancer cells, nanobodies provide superior tumor penetration due to their small size, and extracellular vesicles present a novel platform for drug and RNA delivery. This work aims to review and analyze these three approaches, assessing their current applications, advantages, challenges, and future perspectives.
DOI del artículo:10.3390/biom15050639
Enlace a la fuente original:https://www.mdpi.com/2218-273X/15/5/639
Versión del articulo depositado:info:eu-repo/semantics/publishedVersion
Acceso a la licencia de uso:https://creativecommons.org/licenses/by/3.0/es/
Departamento:Bioquímica i Biotecnologia
URL Documento de licencia:https://repositori.urv.cat/ca/proteccio-de-dades/
Áreas temáticas:Química
Molecular biology
Materiais
General medicine
Farmacia
Ensino
Biochemistry & molecular biology
Biochemistry
Palabras clave:Tria
Target therapy
Target therap
Single-domain antibodies
Neoplasms
Nanobodies
Molecular targeted therapy
Humans
Extracellular vesicles
Engineering exosomes
Egfr
Drug delivery systems
Cancer therapy
Bispecific antibodies
Biomarkers
Antibodies, bispecific
Animals
Entidad:Universitat Rovira i Virgili
Fecha de alta del registro:2025-06-07
Busca tu registro en:

Archivos desponibles
ArchivoDescripciónFormato
DocumentPrincipalDocumentPrincipalapplication/pdf


Información

© 2011 Universitat Rovira i Virgili